Anodyne Nanotech
Joseph Gentile was Vice President and the General Manager at Becton Dickinson Biosciences for over a decade. Over that period, he saw this business grow to over $1.2 Billion in revenue. He is a graduate of Boston University where he earned his M.Eng in Biomedical Engineering and his MBA. He is now a successful board member, strategic advisor, and investor for healthcare companies.
This person is not in the org chart
This person is not in any offices
Anodyne Nanotech
Anodyne Nanotech is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company’s macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules (such as ibuprofen) for fast and sustained delivery.